Canada approves 1st generic semaglutide shot for weight loss
Sentiment Mix
Geography
Expert Signals
Global News - Main Feed
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Canada approves 1st generic semaglutide shot for weight loss.
Supported by 1 story
It's the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.
Supported by 1 story
Related Events
Supreme Court takes up challenges to AR-15 bans
Uncategorized • 6/30/2026
Exclusive: FDA allows ZYN to sell pouches on health benefits - Axios
Uncategorized • 6/30/2026
Ontarians can make their auto insurance cheaper starting July 1 — but opt-in coverage will leave some accident victims ‘out in the cold,’ critics say - Toronto Star
Uncategorized • 6/30/2026
3 vehicles set on fire in Montreal - CTV News
Uncategorized • 6/30/2026
Angine de régime
Uncategorized • 6/30/2026